Which statement best reflects cardiovascular risk management when sedating exotic species?

• A. Always use high-dose alpha-2 agonists to ensure deep sedation.
• B. Exercise caution: avoid high-dose alpha-2 agonists in some species and use minimal sedation with cardiovascular risk monitoring.
• C. Do not monitor cardiovascular status at all.
• D. Do not adjust sedation based on species.

Answer: (B)

Managing cardiovascular risk during sedation of exotic species hinges on using the lowest effective level of sedation and vigilant cardiovascular monitoring, because these animals can vary greatly in their response to sedatives, particularly alpha-2 agonists. Giving high-dose alpha-2 agonists can push some species into severe bradycardia, hypertension with subsequent hypotension, and arrhythmias, so risk is minimized by opting for minimal sedation in combination with careful monitoring rather than aiming for deep sedation. Because species differ in physiology and drug sensitivity, sedation plans should be adjusted to the species and the individual animal, with attention to heart rate, blood pressure, and oxygenation. Skipping cardiovascular monitoring or ignoring species-specific responses would put the patient at risk. Therefore, cautious use of alpha-2 agonists with minimal sedation and ongoing cardiovascular risk monitoring best reflects proper management.